Compare DINO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DINO | RGEN |
|---|---|---|
| Founded | 1947 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 11.0B |
| IPO Year | 2022 | 1995 |
| Metric | DINO | RGEN |
|---|---|---|
| Price | $113.63 | $185.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 21 |
| Target Price | $123.94 | ★ $200.56 |
| AVG Volume (30 Days) | ★ 2.0M | 1.2M |
| Earning Date | 10-28-2026 | 10-27-2026 |
| Dividend Yield | ★ 1.84% | N/A |
| EPS Growth | 238.46 | ★ 286.96 |
| EPS | ★ 8.48 | 0.24 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $31.33 | $14.96 |
| Revenue Next Year | N/A | $26.06 |
| P/E Ratio | ★ $13.47 | $724.65 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $45.71 | $100.99 |
| 52 Week High | $129.37 | $198.87 |
| Indicator | DINO | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 56.01 |
| Support Level | $103.00 | $159.29 |
| Resistance Level | $118.39 | $187.36 |
| Average True Range (ATR) | 5.26 | 8.54 |
| MACD | -1.68 | 0.21 |
| Stochastic Oscillator | 20.30 | 94.77 |
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 350 distributors and 1,700 wholesale branded sites across 30 states. It also owns and operates 4,500 miles of petroleum product pipelines and terminals principally in the southwestern United States.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.